Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of CD47 detection reagent in preparing colorectal cancer anti-EGFR monoclonal antibody drug resistance diagnostic agent

A detection reagent and detection kit technology are applied in the field of diagnostic kits for tumor resistance to anti-EGFR monoclonal antibodies to achieve the effect of reducing curative effect and high-efficiency treatment

Inactive Publication Date: 2019-10-15
THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIV +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the use of Cetuximab and Panitumumab has significantly improved the median survival of CRC patients, however, due to drug resistance, the effective rate of EGFR-targeted drugs in clinical practice is only 8-23%

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of CD47 detection reagent in preparing colorectal cancer anti-EGFR monoclonal antibody drug resistance diagnostic agent
  • Application of CD47 detection reagent in preparing colorectal cancer anti-EGFR monoclonal antibody drug resistance diagnostic agent
  • Application of CD47 detection reagent in preparing colorectal cancer anti-EGFR monoclonal antibody drug resistance diagnostic agent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Example 1. Establishment of Cetuximab-resistant colorectal cell line LIM1215R

[0046] Colorectal cancer cells were cultured in RPMI-1640 medium containing 10% FBS and 1% penicillin and streptomycin; the incubator conditions for the cells were 37°C, 5% CO 2 , saturated humidity and constant temperature. When the cell confluency reached 80-90%, the cells were digested and passaged with 0.25% trypsin. The establishment steps of cetuximab-resistant colorectal cell line LIM1215R are as follows:

[0047] 1. Select the colorectal cancer cell line LIM1215 (European Collection of Authenticated Cell Cultures) sensitive to Cetuximab, and culture the cells in RPMI-1640 medium containing a small concentration of Cetuximab.

[0048] 2. After the cells adapt to the drug concentration environment, gradually add a higher concentration of Cetuximab to the medium until the Cetuximab concentration is 10 μM. At this time, the cells are the colorectal cell line LIM1215R resistant to Cetux...

Embodiment 2

[0051] Example 2. Detection of CD47 RNA expression in Cetuximab-sensitive and drug-resistant colorectal cancer cells

[0052] The RNA of LIM1215 and LIM1215R was extracted, reversed into cDNA, and its expression was detected by qPCR.

[0053] The sequences of CD47 primers used in this experiment are as follows:

[0054] SEQ ID NO.1 forward primer: 5'-AGAAGGTGAAACGATCATCGAGC-3'

[0055] SEQ ID NO.2 reverse primer: 5'-CTCATCCATACCACCGGATCT-3'

[0056] The experimental steps are as follows:

[0057] (1) Remove the culture medium in the cell culture plate, wash with PBS 3 times, then add 1mL Trizol reagent to lyse the cells, pipette evenly until clear, transfer the lysate into a 1.5ml centrifuge tube, and place it at room temperature for 5min ;

[0058] (2) Add 200 μL chloroform to each tube, pipette evenly, and let stand at room temperature for 5 minutes;

[0059] (3) Place the centrifuge tube in a centrifuge at 4°C and centrifuge at 12,000 rpm for 10 minutes, and absorb the...

Embodiment 3

[0080] Example 3. Detection of CD47 Membrane Protein Expression in Cetuximab-sensitive and Drug-resistant Colorectal Cancer Cells

[0081] 1. Remove the medium in the cell culture plate, wash with PBS 3 times, and then digest with trypsin for 2 minutes.

[0082] 2. After terminating the digestion, transfer the cells into a 15mL centrifuge tube with a pipette, centrifuge at 2000rpm for 5min, and wash twice with PBS.

[0083] 3. Resuspend the cells in PBS and adjust the cell density to 1×10 7 / mL, pipette 100 μL into a new centrifuge tube, add 5 μL of FITC anti-human CD47 antibody, incubate at 4°C in the dark for 20 min, and set an isotype control tube for each cell at the same time.

[0084] 4. Add 1mL PBS to each tube, blow and resuspend with a pipette, place the centrifuge tube in a centrifuge and centrifuge at 2000rpm for 5min, discard the supernatant.

[0085] 5. Repeat step 4.

[0086] 6. After the cells were resuspended in 500 μL PBS, the expression level of the cell m...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention belongs to the field of biomedicines and particularly relates to an application of a CD47 detection reagent in preparing a diagnostic kit for tumor anti-EGFR monoclonal antibodydrug resistance and a diagnostic kit for tumor anti-EGFR monoclonal antibody drug resistance. Studies show that CD47 expression is up-regulated in anti-EGFR monoclonal antibody drug resistance colorectal cancer cells compared with anti-EGFR monoclonal antibody sensitive colorectal cancer cells, drug resistance cells with up-regulated CD47 expression result in significantly reduced phagocytosis effect of macrophages, immune escaping of tumor cells, and reduced anti-EGFR monoclonal antibody. CD47 is used as a biomarker for colorectal cancer anti-EGFR monoclonal antibody drug resistance and provides effective prompts for clinical anti-colorectal cancer drug selection, and at the same time, the drug selection efficiently treats colorectal cancers.

Description

technical field [0001] The invention belongs to the field of biomedicine, and specifically relates to the application of a CD47 detection reagent in the preparation of a diagnostic kit for tumor resistance to anti-EGFR monoclonal antibody and a diagnostic kit for tumor resistance to anti-EGFR monoclonal antibody. Background technique [0002] Colorectal cancer (Colorectal Cancer, CRC) is one of the most common malignant tumors with a high lethality rate. In the world, its incidence rate ranks fourth and its mortality rate ranks fifth. In recent years, the morbidity and mortality of CRC have been on the rise in China. According to the data from the 2017 China Cancer Registration Annual Report, the incidence of CRC in China ranks fifth. Surgery combined with radiotherapy and chemotherapy is still the current treatment for CRC. In recent years, with the continuous deepening of research on tumor cell signal transduction pathways, targeted therapy targeting tumor-specific signal...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/6886C12M1/00C12M1/34G01N33/574A61K45/00A61P35/00
CPCA61K45/00A61P35/00C12Q1/6886C12Q2600/106C12Q2600/158G01N33/57419G01N33/57488
Inventor 温创宇王慧慧刘瑞贤陈骏雄李伟倩杨湘玲刘焕亮
Owner THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIV